Evidence map›Paper›PMID 41914026›Full record

ArticleESC heart failure2026

Effect of heart rate reduction with ivabradine on quality of life in advanced cancer patients.

Yvonne Bewarder, Angela Zimmer, Markus Anker, Stefan Anker, Konstantinos Christofyllakis, Moritz Bewarder, Igor Schwantke, Michael Böhm

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ESC heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yvonne BewarderUniversitätsklinikum des Saarlandes, Klinik für Kardiologie, Angiologie und internistische Intensivtherapie, Saarland University, Kirrberger Str. 1, Homburg 66421, Germany.
Angela ZimmerUniversitätsklinikum des Saarlandes, Klinik für Kardiologie, Angiologie und internistische Intensivtherapie, Saarland University, Kirrberger Str. 1, Homburg 66421, Germany.
Markus AnkerDepartment of Cardiology, Angiology and Intensive Care Medicine CBF, German Heart Center Charité, Berlin, Germany.ORCID 0000-0002-4406-8555
Stefan AnkerDepartment of Cardiology (CVK) of German Heart Center Charité, German Centre for Cardiovascular Research (DZHK) Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany.
Konstantinos ChristofyllakisUniversitätsklinikum des Saarlandes, Klinik für Haematologie und Onkologie, Saarland University, Homburg, Germany.
Moritz BewarderUniversitätsklinikum des Saarlandes, Klinik für Haematologie und Onkologie, Saarland University, Homburg, Germany.
Igor SchwantkeUniversitätsklinikum des Saarlandes, Klinik für Kardiologie, Angiologie und internistische Intensivtherapie, Saarland University, Kirrberger Str. 1, Homburg 66421, Germany.
Michael BöhmUniversitätsklinikum des Saarlandes, Klinik für Kardiologie, Angiologie und internistische Intensivtherapie, Saarland University, Kirrberger Str. 1, Homburg 66421, Germany.ORCID 0000-0002-2976-2514

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Advanced cancerIvabradinequality of life

Identifiers

PMID41914026
PMCPMC13036374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.